Alzheimer's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Alzheimer's Disease, including details on diagnosis, memory loss, heredity, treatment, medication.

Volume 2 (2005), Issue 12 (December)

1. Effect of the functional toll-like receptor 4 Asp299Gly polymorphism on susceptibility to late-onset Alzheimer's disease.
   Neurosci Lett, 391(3): 147-9. [Abstract] [Full-text]
2. Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease.
   Neurosci Lett, 391(3): 142-6. [Abstract] [Full-text]
3. Nurr1 in Parkinson's disease and related disorders.
   J Comp Neurol, 494(3): 495-514. [Abstract] [Full-text]
4. Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis.
   Neurosci Lett, 392(3): 235-9. [Abstract] [Full-text]
5. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases.
   Biochem Biophys Res Commun, 339(2): 577-82. [Abstract] [Full-text]
6. Transgenic potato expressing Abeta reduce Abeta burden in Alzheimer's disease mouse model.
   FEBS Lett, 579(30): 6737-44. [Abstract] [Full-text]
7. Relation of blood pressure to risk of incident Alzheimer's disease and change in global cognitive function in older persons.
   Neuroepidemiology, 26(1): 30-6. [Abstract] [Full-text]
8. Change in cognitive function in Alzheimer's disease in African-American and white persons.
   Neuroepidemiology, 26(1): 16-22. [Abstract] [Full-text]
9. Neurovascular coupling in the normal brain and in hypertension, stroke, and Alzheimer disease.
   J Appl Physiol, 100(1): 328-35. [Abstract] [Full-text]
10. Global prevalence of dementia: a Delphi consensus study.
    Lancet, 366(9503): 2112-7. [Abstract] [Full-text]
11. Cholinergic challenge in Alzheimer patients and mild cognitive impairment differentially affects hippocampal activation--a pharmacological fMRI study.
    Brain, 129: 141-57. [Abstract] [Full-text]
12. No association between CYP2D6 polymorphism and Alzheimer's disease in an Italian population.
    Pharmacol Res, 53(2): 162-5. [Abstract] [Full-text]
13. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models.
    Mol Pharmacol, 69(1): 76-84. [Abstract] [Full-text]

© 2004-2008 Alzheimer's Disease Research Today. All Rights Reserved.